US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Curanex Pharmaceuticals

0.2847

+0.00873.15%

Volume:14.24K

Turnover:4.06K

Market Cap:8.07M

PE:-6.25

High:0.2871

Open:0.2840

Low:0.2840

Close:0.2760

52wk High:9.18

52wk Low:0.2620

Shares:28.34M

Float Shares:9.09M

Volume Ratio:0.47

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0455

EPS(LYR):-0.0273

ROE:-17.38%

ROA:-10.08%

PB:0.56

PE(LYR):-10.44

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Curanex Pharmaceuticals Inc - Haiyan Yang Resigns as CFO and Treasurer of Curanex - SEC Filing

THOMSON REUTERS

Curanex Pharmaceuticals Sets CFO Compensation at $20,000 Per Year

Curanex Pharmaceuticals Delays Quarterly Financial Report

Curanex Pharmaceuticals Faces Nasdaq Delisting Warning

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CURX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CURX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","market":"US","secType":"STK","nameCN":"Curanex Pharmaceuticals","latestPrice":0.2847,"timestamp":1770649320612,"preClose":0.276,"halted":0,"volume":14240,"delay":0,"changeRate":0.031521739130434726,"floatShares":9093100,"shares":28340800,"eps":-0.04552,"marketStatus":"Trading","change":0.0087,"latestTime":"02-09 10:03:25 EST","open":0.284,"high":0.2871,"low":0.284,"amount":4055.667344,"amplitude":0.011232,"askPrice":0.29,"askSize":100,"bidPrice":0.2842,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.04552,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770670800000},"marketStatusCode":2,"adr":0,"listingDate":1756180800000,"exchange":"NASDAQ","adjPreClose":0.276,"preHourTrading":{"tag":"盘前","latestPrice":0.276,"preClose":0.276,"latestTime":"08:24 EST","volume":10,"amount":2.7600000000000002,"timestamp":1770643454885,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.276,"preClose":0.276,"latestTime":"16:14 EST","volume":89,"amount":24.388,"timestamp":1770412481332,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.465994},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CURX\",,,,,undefined,":{"symbol":"CURX","floatShares":9093100,"roa":"-10.08%","roe":"-17.38%","lyrEps":-0.027264,"volumeRatio":0.465994,"shares":28340800,"dividePrice":0,"high":0.2871,"amplitude":0.011232,"preClose":0.276,"low":0.284,"week52Low":0.262,"pbRate":"0.56","week52High":9.1796,"institutionHeld":0,"latestPrice":0.2847,"eps":-0.04552,"divideRate":0,"volume":14240,"delay":0,"ttmEps":-0.04552,"open":0.284,"prevYearClose":0.3306,"prevWeekClose":0.276,"prevMonthClose":0.3238,"prevQuarterClose":0.3306,"fiveDayClose":0.3322,"twentyDayClose":0.375,"sixtyDayClose":0.5951},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CURX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CURX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CURX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CURX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CURX","date":"2026-02-06","current":-6.063269,"percent":1,"low":-596.14306,"twenty":-51.809778,"median":-36.025849,"eighty":-8.048981,"high":-5.851898,"avg":-80.684196,"sd":145.483381,"marketCap":7595337},"quantilePoints":[{"date":"2025-08-29","current":-343.821021,"twenty":-323.7357,"median":-309.527845,"eighty":-285.033231,"marketCap":144022500},{"date":"2025-09-05","current":-470.352457,"twenty":-397.745937,"median":-357.40162,"eighty":-309.364317,"marketCap":197025000},{"date":"2025-09-12","current":-522.424684,"twenty":-490.623986,"median":-396.156013,"eighty":-317.040593,"marketCap":227272500},{"date":"2025-09-19","current":-81.3514,"twenty":-518.980126,"median":-404.105632,"eighty":-309.03726,"marketCap":35390625},{"date":"2025-09-26","current":-44.190079,"twenty":-502.869283,"median":-357.40162,"eighty":-78.227506,"marketCap":19224187},{"date":"2025-10-03","current":-52.064896,"twenty":-490.623986,"median":-308.710204,"eighty":-52.935681,"marketCap":22650000},{"date":"2025-10-10","current":-48.094947,"twenty":-477.242127,"median":-89.974648,"eighty":-50.763274,"marketCap":20922937},{"date":"2025-10-17","current":-45.236453,"twenty":-457.103092,"median":-68.335176,"eighty":-47.069268,"marketCap":19679395},{"date":"2025-10-24","current":-42.064901,"twenty":-400.925784,"median":-54.241859,"eighty":-44.399354,"marketCap":18299662},{"date":"2025-10-31","current":-42.99649,"twenty":-384.761559,"median":-51.4271,"eighty":-44.033885,"marketCap":18704935},{"date":"2025-11-07","current":-39.915076,"twenty":-365.54998,"median":-50.763274,"eighty":-43.476372,"marketCap":17364415},{"date":"2025-11-14","current":-36.025849,"twenty":-337.125914,"median":-49.550198,"eighty":-42.216596,"marketCap":15672469},{"date":"2025-11-21","current":-9.181804,"twenty":-310.01843,"median":-47.092697,"eighty":-39.195744,"marketCap":11917311},{"date":"2025-11-28","current":-10.640411,"twenty":-308.710204,"median":-46.699426,"eighty":-38.202616,"marketCap":13810477},{"date":"2025-12-05","current":-9.723323,"twenty":-249.517771,"median":-45.236453,"eighty":-36.025849,"marketCap":12620163},{"date":"2025-12-12","current":-10.048671,"twenty":-98.597896,"median":-44.065693,"eighty":-10.640411,"marketCap":13042441},{"date":"2025-12-19","current":-8.629367,"twenty":-81.3514,"median":-43.511146,"eighty":-10.14693,"marketCap":11200288},{"date":"2025-12-26","current":-8.727626,"twenty":-78.227506,"median":-43.029064,"eighty":-9.899316,"marketCap":11327822},{"date":"2026-01-02","current":-7.218797,"twenty":-71.979719,"median":-42.823377,"eighty":-9.635108,"marketCap":9369472},{"date":"2026-01-09","current":-8.085664,"twenty":-66.382742,"median":-40.152859,"eighty":-9.213247,"marketCap":10494602},{"date":"2026-01-16","current":-8.066012,"twenty":-59.883741,"median":-39.074691,"eighty":-8.778721,"marketCap":10469095},{"date":"2026-01-23","current":-7.948101,"twenty":-54.695471,"median":-38.768503,"eighty":-8.563861,"marketCap":10316055},{"date":"2026-01-30","current":-7.314874,"twenty":-52.092225,"median":-38.100754,"eighty":-8.186981,"marketCap":9494172},{"date":"2026-02-06","current":-5.851898,"twenty":-51.809778,"median":-36.025849,"eighty":-8.048981,"marketCap":7595337}],"updateTime":1770621749969},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CURX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601583294","title":"Curanex Pharmaceuticals Inc - Haiyan Yang Resigns as CFO and Treasurer of Curanex - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601583294","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601583294?lang=en_us&edition=fundamental","pubTime":"2026-01-06 04:45","pubTimestamp":1767645917,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60IK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CURX","BK4007"],"gpt_icon":0},{"id":"2601329928","title":"Curanex Pharmaceuticals Sets CFO Compensation at $20,000 Per Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2601329928","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601329928?lang=en_us&edition=fundamental","pubTime":"2026-01-06 04:43","pubTimestamp":1767645839,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals Inc. has appointed Wanjun Zhang as its new Chief Financial Officer and Treasurer, effective January 1, 2026, following the resignation of Haiyan Yang. In connection with his appointment, the company entered into a consulting agreement with Mr. Zhang for an initial term of two years. Under the agreement, Mr. Zhang will receive an annual compensation of $20,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curanex Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL8QQQxp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CURX"],"gpt_icon":0},{"id":"2584647671","title":"Curanex Pharmaceuticals Delays Quarterly Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2584647671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584647671?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:30","pubTimestamp":1763379027,"startTime":"0","endTime":"0","summary":"Curanex Pharmaceuticals Inc. has disclosed a delay in filing its quarterly report on Form 10-Q for the financial period ended September 30, 2025. The company cited that the report could not be filed on time without unreasonable effort or expense and expects to submit the filing within the allowed extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curanex Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL4NxqSb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX","BK4007"],"gpt_icon":0},{"id":"2581190100","title":"Curanex Pharmaceuticals Faces Nasdaq Delisting Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2581190100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581190100?lang=en_us&edition=fundamental","pubTime":"2025-11-07 02:57","pubTimestamp":1762455452,"startTime":"0","endTime":"0","summary":"The latest update is out from Curanex Pharmaceuticals Inc. ( ($CURX) ). On November 5, 2025, Curanex Pharmaceuticals Inc. received a notification f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/curanex-pharmaceuticals-faces-nasdaq-delisting-warning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/curanex-pharmaceuticals-faces-nasdaq-delisting-warning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ",".IXIC","NVIW.SI","QID","TSYW.SI","SQQQ","MNQmain","BK4007","NQmain","USAW.SI","TQQQ","USJW.SI","CURX","QLD"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CURX\",params:#limit:6,delay:false,,,undefined,":[]}}